Pages that link to "Q42812026"
Jump to navigation
Jump to search
The following pages link to Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity (Q42812026):
Displaying 32 items.
- Cell Proliferation in Neuroblastoma (Q26771708) (← links)
- Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma (Q27303714) (← links)
- Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification (Q33366575) (← links)
- Neuroblastoma as a neurobiological disease (Q33604745) (← links)
- The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. (Q33756262) (← links)
- Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma (Q33794045) (← links)
- Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma (Q34162893) (← links)
- Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines (Q34780646) (← links)
- MYCN, neuroblastoma and focal adhesion kinase (FAK) (Q35208688) (← links)
- MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells (Q35541790) (← links)
- Targeting Focal Adhesion Kinase in Neuroblastoma (Q35576162) (← links)
- Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival (Q35642231) (← links)
- MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model (Q35791530) (← links)
- Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma (Q35832541) (← links)
- Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation (Q35912185) (← links)
- KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma (Q36171505) (← links)
- Genistein, a dietary-derived inhibitor of in vitro angiogenesis (Q36192742) (← links)
- FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma (Q36763037) (← links)
- The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis (Q38070334) (← links)
- The MYCN Protein in Health and Disease (Q39208675) (← links)
- The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma (Q39621978) (← links)
- Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. (Q39736018) (← links)
- Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma. (Q40243281) (← links)
- A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation. (Q40944839) (← links)
- The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells (Q41083303) (← links)
- Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity (Q41393608) (← links)
- Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number (Q41620256) (← links)
- CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells (Q42227825) (← links)
- SH-EP007 (Q54953213) (← links)
- WAC2 (Q54993536) (← links)
- Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth (Q57062990) (← links)
- Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma (Q90276849) (← links)